scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/0005-2760(91)90032-D |
P698 | PubMed publication ID | 1903657 |
P2093 | author name string | D L DeWitt | |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 121-134 | |
P577 | publication date | 1991-05-01 | |
P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
P1476 | title | Prostaglandin endoperoxide synthase: regulation of enzyme expression | |
P478 | volume | 1083 |
Q105154618 | A new 14,15-dinor-labdane Glucoside from Crassocephalum Mannii |
Q34546270 | A review of in vitro and in vivo studies on the efficacy of herbal medicines for primary dysmenorrhea |
Q28192297 | Absence of nuclear factor kappaB inhibition by NSAIDs in hepatocytes |
Q37560421 | Acetylsalicylic acid interferes with embryonic kidney growth and development by a prostaglandin-independent mechanism. |
Q73084769 | Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1 |
Q44030362 | Activation of monocyte cyclooxygenase-2 gene expression by human herpesvirus 6. Role for cyclic AMP-responsive element-binding protein and activator protein-1. |
Q41380325 | Activin A and retinoic acid synergize in cyclooxygenase-1 and thromboxane synthase induction during differentiation of J774.1 macrophages |
Q90662271 | Analysis of the Activity and Expression of Cyclooxygenases COX1 and COX2 in THP-1 Monocytes and Macrophages Cultured with BiodentineTM Silicate Cement |
Q40496125 | Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through small GTPases using distinct signaling pathways |
Q39973660 | Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells |
Q43655092 | Anti-inflammatory activity of abietic acid, a diterpene isolated from Pimenta racemosa var. grissea. |
Q24241893 | Anti-inflammatory agents for preventing the progression of cervical intraepithelial neoplasia |
Q24250572 | Anti-inflammatory agents for preventing the progression of cervical intraepithelial neoplasia |
Q44012085 | Anti-inflammatory and antioxidative effects of the methanolic extract of the aerial parts of Mitracarpus frigidus in established animal models. |
Q52183289 | Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window. |
Q42831782 | Arachidonic acid inhibits osteoblast differentiation through cytosolic phospholipase A2-dependent pathway |
Q71573522 | Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety |
Q28174019 | Aspirin induces its anti-inflammatory effects through its specific binding to phospholipase A2: crystal structure of the complex formed between phospholipase A2 and aspirin at 1.9 angstroms resolution |
Q34502076 | Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis. |
Q34111034 | Attenuated prostaglandin formation in peroxisomal-deficient human skin fibroblasts |
Q34201538 | Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide |
Q33822140 | Basic biology and clinical application of specific cyclooxygenase-2 inhibitors |
Q33751430 | Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs |
Q77800006 | Biomarkers of free radical damage applications in experimental animals and in humans |
Q73794765 | Bradykinin potentiates prostaglandin E(2) release in the human gingival fibroblasts pretreated with interleukin-1beta via Ca(2+) mobilization |
Q40652736 | C-Phycocyanin, a selective cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide-stimulated RAW 264.7 macrophages |
Q98174630 | COX-2 gene rs689466 polymorphism is associated with increased risk of colorectal cancer among Caucasians: a meta-analysis |
Q37691478 | COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex |
Q42743950 | COX-2: a link between airway inflammation and disordered chloride secretion in cystic fibrosis? |
Q28567112 | CREB-dependent cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression is mediated by protein kinase C and calcium |
Q44710269 | Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride-associated hepatotoxicity in rats |
Q40913508 | Characterization of a novel transcript of prostaglandin endoperoxide H synthase 1 with a tissue-specific profile of expression |
Q43496701 | Characterization of prostaglandin H synthase 2 deficient mice and implications for mechanisms of NSAID action |
Q34585612 | Comparison of analgesic and anti-inflammatory efficacy of selective and non-selective cyclooxygenase-2 inhibitors in dental implant surgery |
Q39434859 | Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial |
Q44374395 | Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection Constitutive COX-2 expression and cardioprotection. |
Q71844026 | Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in hum an tracheal epithelial cells in vitro |
Q73182600 | Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double His513 --> Arg and Ile523 --> val mutation |
Q35581260 | Cox-2 Selective Inhibitors and Bone |
Q40262676 | Cyclo-oxygenase 2 expression impairs serum-withdrawal-induced apoptosis in liver cells. |
Q24675327 | Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy |
Q48114396 | Cycloheximide rapidly inhibits cortical COX activity and COX-dependent pial arteriolar dilation in piglets |
Q41165164 | Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy |
Q42461540 | Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. |
Q35581225 | Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. |
Q35547033 | Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. |
Q34132261 | Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. |
Q34409188 | Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats |
Q37222340 | Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1 |
Q47910140 | Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases |
Q24648434 | Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors |
Q80943593 | Cyclooxygenase-2 expression in human thyroid disease |
Q43844193 | Cyclooxygenase-2 is expressed by cumulus cells during oocyte maturation in cattle |
Q44118749 | Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma |
Q39260965 | Cyclooxygenase-2 over-expression inhibits liver apoptosis induced by hyperglycemia. |
Q46538912 | Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha |
Q40188109 | Cyclooxygenase-2-dependent prostaglandin E(2) upregulates interleukin (IL)-1alpha-induced IL-6 generation in mouse cementoblasts |
Q46125184 | Cyclooxygenase-2-derived prostaglandin E2 is involved in vascular endothelial growth factor production in interleukin-1alpha-stimulated human periodontal ligament cells |
Q33539473 | Cyclooxygenase-dependent signalling: molecular events and consequences |
Q45372711 | Cyclooxygenase‐2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression |
Q73042233 | Cyclosporin A upregulates prostaglandin E2 production in human gingival fibroblasts challenged with tumor necrosis factor alpha in vitro |
Q45103722 | Cytokine regulation of adult human osteoblast-like cell prostaglandin biosynthesis |
Q40572491 | Cytokine regulation of eicosanoid generation |
Q68028126 | Cytokine- and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone |
Q73805378 | Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours |
Q37065177 | Decreased expression of 15-hydroxyprostaglandin dehydrogenase in gastric carcinomas |
Q43932785 | Detection of a higher oxidation state of manganese-prostaglandin endoperoxide synthase |
Q42832992 | Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts |
Q41330461 | Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro |
Q42806855 | Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins |
Q23918456 | Diseases caused by silica: mechanisms of injury and disease development |
Q40977643 | Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation. Implications for future anti-inflammatory therapy |
Q34548938 | Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea |
Q42636683 | Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation |
Q45197080 | Down-regulation of interleukin-1alpha-induced matrix metalloproteinase-13 expression via EP1 receptors by prostaglandin E2 in human periodontal ligament cells |
Q43587707 | Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2/EP4 receptors by prostaglandin E2 in human fibroblasts |
Q28367719 | Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors |
Q42186834 | EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts. |
Q71594816 | Effect of Trolox C on the oxygenation reaction of prostaglandin endoperoxide synthase with cis,cis-eicosa-11, 14-dienoic acid |
Q53429888 | Effect of hormonal status on the expression of the cyclooxygenase 1 and 2 genes and prostaglandin synthesis in rat mammary glands. |
Q42443189 | Effect of interleukin-4 on allergen-induced arachidonic acid metabolism of rat peritoneal macrophages during immediate hypersensitivity reactions |
Q44796493 | Effect of oxybenzone on PGE2-production in vitro and on plaque and gingivitis in vivo |
Q46429525 | Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice |
Q46494389 | Effect of vitamin E and indomethacin treatment on adenylate cyclase activity, PGE2 and cAMP levels in murine melanoma cells |
Q48443177 | Effects of anoxic stress on prostaglandin H synthase isoforms in piglet brain |
Q48368760 | Effects of ischemia on prostaglandin H synthase-2 expression in piglet choroid plexus |
Q42276009 | Effects of nabumetone on prostanoid biosynthesis in humans. |
Q73026346 | Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress-induced gastric lesions in rats |
Q73026375 | Effects of non-steroidal anti-inflammatory drugs on prostaglandin E2 production by cyclooxygenase-2 from endogenous and exogenous arachidonic acid in rat peritoneal macrophages stimulated with lipopolysaccharide |
Q35872952 | Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostagl |
Q41537341 | Eicosanoids and inflammatory bowel disease |
Q72193010 | Endothelin-1 induction of cyclooxygenase-2 expression in rat mesangial cells |
Q44590042 | Enhanced expression of cylooxygenase-2 by UV in aged human skin in vivo |
Q33897429 | Enhanced prostacyclin synthesis in endothelial cells by retrovirus-mediated transfer of prostaglandin H synthase cDNA |
Q43936313 | Epidural injection of cyclooxygenase-2 inhibitor attenuates pain-related behavior following application of nucleus pulposus to the nerve root in the rat. |
Q31919638 | Estrogen enhances mechanical stress-induced prostaglandin production by bone cells from elderly women |
Q37236040 | Estrogen-mediated protection in myocardial ischemia-reperfusion injury |
Q64270724 | Evaluation of the Effect of Antidepressant Drug, Fluvoxamine, on Cyclooxygenase-2 Protein Expression in Lipopolysaccharide-stimulated Macrophages |
Q31152796 | Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis |
Q43212326 | Expression and activities of three inducible enzymes in the healing of gastric ulcers in rats |
Q42008475 | Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux |
Q44962246 | Expression of cyclooxygenase-2 and nitric oxide synthase 2 in swine ulcerative colitis caused by Salmonella typhimurium |
Q35028167 | Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines. |
Q53428385 | Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. |
Q48333638 | Expression of mRNAs for vasopressin, oxytocin and corticotrophin releasing hormone in the hypothalamus, and of cyclooxygenases-1 and -2 in the cerebral vasculature, of endotoxin-challenged pigs |
Q53364964 | Expression of proteins related to prostaglandin E2 biosynthesis is increased in human gastric cancer and during gastric carcinogenesis. |
Q41100111 | Expression of the two isoforms of prostaglandin endoperoxide synthase (PGHS-1 and PGHS-2) during adipose cell differentiation |
Q28192787 | Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation |
Q30872702 | Functional analysis of the molecular determinants of cyclooxygenase-2 acetylation by 2-acetoxyphenylhept-2-ynyl sulfide |
Q82270879 | Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma |
Q73211997 | Gangliosides activate cultured rat brain microglia |
Q42832084 | Gastrin-releasing peptide-induced expression of prostaglandin synthase-2 in Swiss 3T3 cells |
Q36162961 | Gelam Honey Inhibits the Production of Proinflammatory, Mediators NO, PGE(2), TNF-α, and IL-6 in Carrageenan-Induced Acute Paw Edema in Rats. |
Q24293134 | Human cyclooxygenase-2 cDNA |
Q72898137 | Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines |
Q42822657 | Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages |
Q58172374 | Immunosuppression and anti-inflammatory agents in ALS |
Q49304845 | In Vitro Effect of 3D Plates Used for Surgical Treatment of Condylar Fractures on Prostaglandin E₂ (PGE₂) and Thromboxane B₂ (TXB₂) Concentration in THP-1 Macrophages |
Q35596979 | Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins |
Q80971959 | Increased prostaglandin H synthase-1 expression and activity level in stably Harvey-ras transfected C3H10T1/2 cells |
Q61053473 | Inducible cyclooxygenase may have anti-inflammatory properties |
Q41214629 | Induction of cyclo-oxygenase and nitric oxide synthase in inflammation |
Q35763802 | Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine |
Q37360260 | Induction of diaphragmatic nitric oxide synthase after endotoxin administration in rats: role on diaphragmatic contractile dysfunction. |
Q45066847 | Induction of microsomal prostaglandin E synthase-1 in human gingival fibroblasts |
Q35873648 | Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation. |
Q68213246 | Induction of thromboxane synthase and prostaglandin endoperoxide synthase mRNAs in human erythroleukemia cells by phorbol ester |
Q37298650 | Inflammation and prostate cancer. |
Q44115420 | Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer |
Q42537950 | Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells |
Q39451400 | Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages |
Q40923718 | Inhibition of NOS-2 expression in macrophages through the inactivation of NF-kappaB by andalusol. |
Q44188961 | Inhibition of prostaglandin E(2) production by taiwanin C isolated from the root of Acanthopanax chiisanensis and the mechanism of action |
Q52052998 | Inhibitors of Cyclooxygenases produce Amnesia for a Passive Avoidance Task in the Chick |
Q74232004 | Interaction between NSAIDs and steroid in rat stomach: safety of nimesulide as a preferential COX-2 inhibitor in the stomach |
Q40572564 | Interactions of PGH synthase isozymes-1 and -2 with NSAIDs |
Q41100279 | Interactions of nitric oxide with cyclooxygenase: in vitro, ex vivo, and in vivo studies |
Q41088177 | Interleukin-1 receptor antagonist blocks interleukin-1-induced expression of cyclooxygenase-2 in endometrium |
Q44783594 | Interleukin-1beta induces matrix metalloproteinase-1 expression in cultured human gingival fibroblasts: role of cyclooxygenase-2 and prostaglandin E2. |
Q46599828 | Interleukin-1beta-induced prostaglandin E2 production by human gingival fibroblasts is upregulated by glycine |
Q74582165 | Interleukin-4 and interferon-gamma inhibit prostaglandin production by interleukin-1beta-stimulated human periodontal ligament fibroblasts |
Q33578993 | Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I. |
Q50987004 | Internal prostaglandin synthesis augments osteoprotegerin production in human gingival fibroblasts stimulated by lipopolysaccharide. |
Q53342780 | Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. |
Q48708462 | Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages |
Q42822738 | Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells |
Q48114385 | Ischemia-reperfusion rapidly increases COX-2 expression in piglet cerebral arteries |
Q52143962 | Kinetics of prostanoid synthesis by macrophages is regulated by arachidonic acid sources. |
Q41026596 | Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth |
Q34040447 | Management of Inflammatory Pain with Selective COX-2 Inhibitors: Promises and Facts |
Q64112740 | Maprotiline inhibits and gene expression in lipopolysaccharide-stimulated U937 macrophages and carrageenan-induced paw edema in rats |
Q73298997 | Mechanical stress induces COX-2 mRNA expression in bone cells from elderly women |
Q41528610 | Mechanism of action of aspirin-like drugs |
Q44775083 | Mechanisms of lipopolysaccharide-induced changes in effects of contractile agonists on pregnant rat myometrium |
Q42826015 | Medium change amplifies mitogen-activated protein kinase-mediated prostaglandin E2 synthesis in Swiss 3T3 fibroblasts |
Q46162897 | Mitogen-inducible prostaglandin G/H synthase is expressed in canine mastocytoma cells |
Q37371806 | Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2. |
Q44464626 | Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. |
Q40989686 | Modulation of the UVA activation of haem oxygenase, collagenase and cyclooxygenase gene expression by epigallocatechin in human skin cells |
Q40830399 | Molecular biology in the eicosanoid field |
Q28295523 | Molecular characterization of the 5.2 KB isoform of the human cyclooxygenase-1 transcript |
Q36698125 | Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes |
Q41915483 | Myeloid differentiation factor 88-dependent post-transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: tumor necrosis factor-alpha receptor-associated factor 6, a diverging point in the Toll-like receptor 9-signaling |
Q31834326 | NO regulates LPS-stimulated cyclooxygenase gene expression and activity in pulmonary artery endothelium |
Q40465951 | Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response. |
Q40476391 | New insights into the mode of action of anti-inflammatory drugs |
Q41113860 | New insights into the site and mode of antinociceptive action of flurbiprofen enantiomers |
Q42517231 | Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism |
Q36457941 | Nitric oxide activates cyclooxygenase enzymes. |
Q47888179 | Nitric oxide enhances prostaglandin production in ethanol-induced gastric mucosal injury in rats |
Q35071868 | Nitric oxide in liver inflammation and regeneration |
Q39765589 | Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators |
Q24197474 | Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia |
Q50065350 | Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. |
Q40762827 | On radiation damage to normal tissues and its treatment. II. Anti-inflammatory drugs |
Q34323748 | Pathophysiology of bone pain: a review |
Q33610044 | Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules |
Q40581037 | Peptidoglycan induces nuclear factor-kappaB activation and cyclooxygenase-2 expression via Ras, Raf-1, and ERK in RAW 264.7 macrophages |
Q73494721 | Peroxidase-Dependent Bioactivation and Oxidation of DNA and Protein in Benzo[a]Pyrene-Initiated Micronucleus Formation |
Q34348724 | Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury |
Q42072129 | Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney |
Q40664642 | Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. |
Q37383735 | Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer |
Q44905419 | Platelet-derived growth factor-induced arachidonic acid release for enhancement of prostaglandin E(2) synthesis in human gingival fibroblasts pretreated with interleukin-1beta |
Q77453689 | Production of prostaglandins E1 and E2 by adult human red blood cells |
Q47278840 | Production of prostanoids via increased cyclo-oxygenase-2 expression in human amnion cells in response to low molecular weight hyaluronic acid fragment |
Q40727424 | Prostaglandin E(2) production and induction of prostaglandin endoperoxide synthase-2 is inhibited in a murine macrophage-like cell line, RAW 264.7, by Mallotus japonicus phloroglucinol derivatives |
Q78190813 | Prostaglandin E2 downregulates interferon-gamma-induced intercellular adhesion molecule-1 expression via EP2 receptors in human gingival fibroblasts |
Q44457834 | Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes. |
Q71823569 | Prostaglandin G/H Synthase-2 Is a Major Contributor of Brain Prostaglandins in the Newborn |
Q34475717 | Prostaglandin biology |
Q73511387 | Prostaglandin levels in BL6 melanoma cells cultured in vitro: the effect of vitamin E succinate supplementation |
Q35850629 | Prostanoids and their receptors that modulate dendritic cell-mediated immunity |
Q58842339 | Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes |
Q34141454 | Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene |
Q33754811 | Psoriasis and the arachidonic acid cascade |
Q42809268 | Pyrrolidine dithiocarbamate induces cyclooxygenase-2 expression in NIH 3T3 fibroblast cells |
Q73093618 | Quantitative analysis of cyclooxygenase-2 gene expression on acute gastric injury induced by ischemia-reperfusion in rats |
Q41962066 | Rapid and transient induction of cyclo-oxygenase 2 by epidermal growth factor in human amnion-derived WISH cells |
Q26852195 | Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications |
Q36090929 | Regional Differences in the Neuronal Expression of Cyclooxygenase-2 (COX-2) in the Newborn Pig Brain |
Q48470743 | Regional distribution of prostaglandin H synthase-2 and neuronal nitric oxide synthase in piglet brain |
Q33705458 | Regulation and metabolism of arachidonic acid |
Q41910302 | Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts |
Q40046885 | Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine |
Q73684614 | Regulation of cyclooxygenase gene expression in rat endometrial stromal cells: the role of epidermal growth factor |
Q71532968 | Regulation of platelet-derived growth factor isoform-mediated expression of prostaglandin G/H synthase in mesangial cells |
Q44265025 | Regulation of prostaglandin generation in carrageenan-induced pleurisy by inducible nitric oxide synthase in knockout mice |
Q42013248 | Regulation of prostaglandin production by nitric oxide; an in vivo analysis |
Q40504265 | Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. |
Q41126924 | Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages |
Q44259838 | Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion |
Q34118003 | Resolution of inflammation. |
Q37142408 | Resolvin D1 protects periodontal ligament |
Q46941491 | Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor |
Q39751648 | Risk assessment of tetrabromobisphenol A on cyclooxygenase-2 expression via MAP kinase/NF-kappaB/AP-1 signaling pathways in murine macrophages |
Q43798440 | Role of cyclopentenone prostaglandins in rat carrageenin pleurisy |
Q40775016 | Role of phospholipases A(2) in growth-dependent changes in prostaglandin release from 3T6 fibroblasts |
Q44350381 | Role of prostaglandin H2 synthase 2 in murine parturition: study on ovariectomy-induced parturition in prostaglandin F receptor-deficient mice |
Q35026075 | Selective induction of cyclo-oxygenase-2 activity in the permanent human endothelial cell line HUV-EC-C: biochemical and pharmacological characterization. |
Q37222349 | Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells |
Q73020094 | Staphylococcal exoproducts down-regulate cyclooxygenase 1 and 2 in peritoneal macrophages |
Q38532042 | Staurosporine induces de novo synthesis of prostaglandin H synthase-2 in rat alveolar macrophages |
Q44079534 | Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition. identification of novel chemotherapeutic drug resistance modulators. |
Q43196763 | Sulindac prevents esophageal adenocarcinomas induced by gastroduodenal reflux in rats |
Q44754569 | Syntheses of prostaglandin E2 and E-cadherin and gene expression of beta-defensin-2 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans |
Q38981137 | Synthesis, toxicity study and anti-inflammatory effect of MHTP, a new tetrahydroisoquinoline alkaloid |
Q34103524 | TTF-1 action on the transcriptional regulation of cyclooxygenase-2 gene in the rat brain |
Q47414996 | Target size analysis of prostaglandin endoperoxide synthase. Radiation inactivation of both cyclooxygenase and peroxidase correlated with the monomer of 72 kDa |
Q42279585 | Tepoxalin, a novel dual inhibitor of the prostaglandin-H synthase cyclooxygenase and peroxidase activities |
Q27731226 | The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 |
Q54580704 | The blockade of cyclooxygenases-1 and -2 reduces the effects of hypoxia on endothelial cells. |
Q73484282 | The mechanism of thrombin-induced prostacyclin synthesis in human endothelial cells with reference to the gene transcription of prostacyclin-related enzymes and Ca2+ kinetics |
Q37946399 | The role of prostaglandin E2 in endometriosis |
Q38297445 | The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts |
Q40524213 | The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway |
Q28394424 | Therapies targeting lipid peroxidation in traumatic brain injury |
Q37272575 | Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis |
Q41772573 | Topical glucocorticoids and the skin--mechanisms of action: an update. |
Q37037181 | Toxicity and carcinogenicity mechanisms of fibrous antigorite |
Q73313666 | Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxide synthases |
Q41004291 | Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues |
Q42806232 | Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum |
Q40903265 | Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells |
Q50734065 | Transgenic mouse for conditional, tissue-specific Cox-2 overexpression. |
Q45218127 | Triclosan reduces microsomal prostaglandin E synthase-1 expression in human gingival fibroblasts. |
Q41561187 | Tumor necrosis factor-alpha potentiates phospholipase A2-stimulated release and metabolism of arachidonic acid in cultured intestinal epithelial cells (INT 407). |
Q44411492 | Tyrosine Phosphorylation of I-κB Kinase α/β by Protein Kinase C-Dependent c-Src Activation Is Involved in TNF-α-Induced Cyclooxygenase-2 Expression |
Q36743743 | Tyrosyl radicals and their role in hydroperoxide-dependent activation and inactivation of prostaglandin endoperoxide synthase |
Q77119084 | [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase] |
Q36666887 | v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element |
Search more.